Brand name versus generic warfarin: a systematic review of the literature.
about
Generic versus brand-name drugs used in cardiovascular diseasesDesign and rationale for the WARFA trial: a randomized controlled cross-over trial testing the therapeutic equivalence of branded and generic warfarin in atrial fibrillation patients in Brazil.Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation.Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty.Factors affecting the opinions of family physicians regarding generic drugs--a questionnaire based studyLikelihood approach for evaluating bioequivalence of highly variable drugs.Generic medicines and generic substitution: contrasting perspectives of stakeholders in IrelandVariations in Patients' Perceptions and Use of Generic Drugs: Results of a National SurveyBiosimilars in rheumatic diseases: structural and functional variability that may impact clinical and regulatory decisions.Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.Generic switching of warfarin and risk of excessive anticoagulation: a Danish nationwide cohort study.Warfarin brands.Generic versus brand name: the other drug war.Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
P2860
Q26775920-B954886C-FE0B-4558-A7D1-36F592EDA68DQ33776631-34410826-73D0-4D7A-BC11-513BEA2B0F4DQ34672296-72034423-9472-4EC1-96BD-4556FC5E4F3DQ34938763-A65D9F07-7A20-4A51-BCCE-AEFA937E7C08Q35194382-FC2FA1C5-8213-4337-8C6E-A21D8915960BQ35786205-0F0C4CED-C40B-4C98-B010-37B943879300Q35869235-03E684F8-977F-4E47-AA27-EE69C4D61040Q36910120-2ED1F8E7-97AD-499F-AC5C-9A503079C5A7Q38974661-F00DE278-432F-4BAF-ACFC-CD7EBD1BDE49Q40099619-6A451333-286D-4876-B222-F3DE020680AEQ40179302-D5BD692B-B7FA-4E02-B06F-6D345BCC4A65Q41865874-CFD52046-74E1-462F-8AE5-58C4282CA2DEQ42944062-B5277CFA-0AC2-4C32-A004-69E77E2CDBB3Q43698781-55BC8F40-5B43-44F6-BB64-C213749D23CC
P2860
Brand name versus generic warfarin: a systematic review of the literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brand name versus generic warfarin: a systematic review of the literature.
@en
Brand name versus generic warfarin: a systematic review of the literature.
@nl
type
label
Brand name versus generic warfarin: a systematic review of the literature.
@en
Brand name versus generic warfarin: a systematic review of the literature.
@nl
prefLabel
Brand name versus generic warfarin: a systematic review of the literature.
@en
Brand name versus generic warfarin: a systematic review of the literature.
@nl
P2093
P2860
P356
P1433
P1476
Brand name versus generic warfarin: a systematic review of the literature.
@en
P2093
Dan M Witt
David Garcia
Francesco Dentali
Marco P Donadini
Mark A Crowther
Nathan Clark
Warfarin Associated Research Projects and Other Endeavors (WARPED) Consortium
P2860
P304
P356
10.1592/PHCO.31.4.386
P407
P577
2011-04-01T00:00:00Z